Bristol Myers Squibb Non-GAAP EPS of $1.99 beats by $0.16, revenue of $11.22B beats by $40M, re-affirms FY22 outlook
Bristol Myers Squibb Non-GAAP EPS of $1.99 beats by $0.16, revenue of $11.22B beats by $40M, re-affirms FY22 outlook Source link